Cyclosporin A Protected Cardiomyocytes Against Oxidative Stress Injury by Inhibition of NF- κ B Signaling Pathway

ConclusionsCsA protected cardiomyocytes against H2O2-induced cell injury. Hence, CsA may be developed as a candidate drug to prevent or treat myocardial ischemia reperfusion injury.
Source: Cardiovascular Engineering and Technology - Category: Cardiology Source Type: research